secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001493152-25-006890
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health resolves Nasdaq listing violation by amending warrants; compliance regained but risk remains
--------------------------------------------------------------------------------

- Received Nasdaq notice Feb 11, 2025 for violating Rule 5635(c) by issuing shares/warrants below market value without shareholder approval.
- Amended warrants same day to prohibit exercise until shareholder approval, regaining compliance with Nasdaq.
- Private placement involved 1,264,739 shares and warrants at $1.53/unit; market value per unit was $1.595.
- Company cautions there is no guarantee its common stock will remain listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315225006890/0001493152-25-006890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315225006890/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer